Skip to content
HowShorted

MADRIGAL PHARMACEUTICALS, INC. short interest in 2020

In 2020, MADRIGAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 15.62% of shares outstanding on 15 Jan 2020 to 17.74% on 31 Dec 2020, a change of +2.12 percentage points. The year's high was 21.97% on 30 Apr 2020 and its low 15.32% on 13 Nov 2020, averaging 17.71% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 44.33 days on 31 Aug 2020. Full history: MADRIGAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MADRIGAL PHARMACEUTICALS, INC. in 2020

2020 in figures

Start of year
15.62% (15 Jan 2020)
End of year
17.74% (31 Dec 2020)
Change
+2.12 pp
High
21.97% (30 Apr 2020)
Low
15.32% (13 Nov 2020)
Average
17.71%
Highest days to cover
44.33 (31 Aug 2020)
SEC filings marked
8

Every report in 2020

MADRIGAL PHARMACEUTICALS, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202015.62%15.92
31 Jan 202016.67%13.55
14 Feb 202016.82%26.34
28 Feb 202016.49%18.3110-K filed, results (8-K)
13 Mar 202015.88%14.51
31 Mar 202018.83%13.28
15 Apr 202021.94%14.55
30 Apr 202021.97%16.03
15 May 202020.30%13.4110-Q filed, results (8-K)
29 May 202018.52%14.85
15 Jun 202018.84%26.22
30 Jun 202019.06%23.24
15 Jul 202018.18%23.40
31 Jul 202018.29%39.41
14 Aug 202018.36%35.9410-Q filed, results (8-K)
31 Aug 202018.02%44.33
15 Sep 202018.48%20.14
30 Sep 202015.91%11.75
15 Oct 202015.91%20.82
30 Oct 202016.04%31.06
13 Nov 202015.32%18.0410-Q filed, results (8-K)
30 Nov 202016.15%18.50
15 Dec 202015.76%21.93
31 Dec 202017.74%14.37

See also: MADRIGAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.